0.945
price up icon5.35%   0.048
after-market After Hours: .95 0.005 +0.53%
loading

Tempest Therapeutics Inc Stock (TPST) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Interest Income/Expense
2.39%
0.368
0.377 0.373 0.355 0.344
Operating Income/Loss
6.12%
-7.974
-7.514 -6.592 -7.47 -7.581
Nonoperating Income/Loss
169.23%
0.07
0.026 -0.194 -0.111 -0.055
Income/Loss From Continuing Operations Before Tax
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Net Income/Loss
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,538%
22.23
1.3572 14.12 14.10 13.76
Diluted Average Shares
1,538%
22.23
1.3572 14.12 14.10 13.76
Basic Earnings Per Share
5.88%
-0.36
-0.34 -0.48 -0.54 -0.55
Diluted Earnings Per Share
5.88%
-0.36
-0.34 -0.48 -0.54 -0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Cap:     |  Volume (24h):